These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 18688798)

  • 21. LRRK2 G2385R and LRRK2 R1628P increase risk of Parkinson's disease in a Han Chinese population from Southern Mainland China.
    Fu X; Zheng Y; Hong H; He Y; Zhou S; Guo C; Liu Y; Xian W; Zeng J; Li J; Liu Z; Chen L; Pei Z
    Parkinsonism Relat Disord; 2013 Mar; 19(3):397-8. PubMed ID: 22981185
    [No Abstract]   [Full Text] [Related]  

  • 22. Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease.
    Ross OA; Wu YR; Lee MC; Funayama M; Chen ML; Soto AI; Mata IF; Lee-Chen GJ; Chen CM; Tang M; Zhao Y; Hattori N; Farrer MJ; Tan EK; Wu RM
    Ann Neurol; 2008 Jul; 64(1):88-92. PubMed ID: 18412265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LRRK2 G2019S founder haplotype in the Chinese population.
    Tan EK; Skipper L; Tan L; Liu JJ
    Mov Disord; 2007 Jan; 22(1):105-7. PubMed ID: 17083102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leucine-rich repeat kinase 2 for beginners: six key questions.
    Kett LR; Dauer WT
    Cold Spring Harb Perspect Med; 2012 Mar; 2(3):a009407. PubMed ID: 22393539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical features of LRRK2 parkinsonism.
    Haugarvoll K; Wszolek ZK
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S205-8. PubMed ID: 20082991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lrrk2 R1628P in non-Chinese Asian races.
    Tan EK; Tang M; Tan LC; Wu YR; Wu RM; Ross OA; Zhao Y
    Ann Neurol; 2008 Oct; 64(4):472-3. PubMed ID: 18688798
    [No Abstract]   [Full Text] [Related]  

  • 27. The importance of LRRK2 mutations in Parkinson disease.
    Schapira AH
    Arch Neurol; 2006 Sep; 63(9):1225-8. PubMed ID: 16966498
    [No Abstract]   [Full Text] [Related]  

  • 28. PARK8 LRRK2 parkinsonism.
    Haugarvoll K; Wszolek ZK
    Curr Neurol Neurosci Rep; 2006 Jul; 6(4):287-94. PubMed ID: 16822348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wild-type LRRK2 as a new potential therapeutic target in idiopathic Parkinson's disease.
    Sanjari Moghaddam H; Aarabi MH
    Mov Disord; 2018 Dec; 33(12):1876. PubMed ID: 30452792
    [No Abstract]   [Full Text] [Related]  

  • 30. The pleomorphic pathology of inherited Parkinson's disease: lessons from LRRK2.
    Bonifati V
    Curr Neurol Neurosci Rep; 2006 Sep; 6(5):355-7. PubMed ID: 16928343
    [No Abstract]   [Full Text] [Related]  

  • 31. Genetic characteristics of leucine-rich repeat kinase 2 (LRRK2) associated Parkinson's disease.
    Bardien S; Lesage S; Brice A; Carr J
    Parkinsonism Relat Disord; 2011 Aug; 17(7):501-8. PubMed ID: 21641266
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.